Munro J M, Cotran R S
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
Lab Invest. 1988 Mar;58(3):249-61.
Current concepts of the pathogenesis of atherosclerosis have been reviewed, emphasizing some of the similarities of the mechanisms and events involved to those in inflammation. Figure 2 is a schematic summary of these events. Hyperlipidemia, or some component of hyperlipidemic serum, as well as other risk factors, are thought to cause endothelial injury, resulting in adhesion of platelets and/or monocytes and release of PDGF (and other growth factors), which leads to smooth muscle migration and proliferation. It is clear that endothelial injury need not be denuding, and in fact may consist of altered endothelial function (dysfunction); adhesion of monocytes, increased permeability of endothelium, and disturbances in growth control can occur without morphologically obvious endothelial injury. Hyperlipidemia, hypertension, smoking, immune injury, and other risk factors may contribute to this endothelial dysfunction in different ways and sometimes in combination. Smooth muscle cells produce large amounts of collagen, elastin, and proteoglycans and these form part of the atheromatous plaque. Hyperlipidemia contributes in a number of ways (as discussed earlier), and indeed, in the severely hypercholesterolemic patient, such as one with familial hypercholesterolemia, is alone sufficient to cause atherosclerosis in the absence of other risk factors. Foam cells of atheromatous plaques are derived both from macrophages and from smooth muscle cells; from macrophages via the beta-VLDL receptor and also possibly by way of LDL modification, recognized by the acetyl-LDL receptor (such as oxidized LDL); and from smooth muscle cells by less certain mechanisms. Extracellular lipid is derived from insudation from the lumen, particularly in the presence of hypercholesterolemia, and also from degenerating foam cells. Cholesterol accumulation in the plaque should be viewed as reflecting imbalance between influx and efflux, and it is possible that high-density lipoprotein is the molecule which helps clear the cholesterol from these accumulations (134). The diagram (right) also depicts the possibility that smooth muscle proliferation may occur without endothelial injury at all. There are several postulated mechanisms for such an occurrence: loss of growth control, direct smooth muscle injury (such as by LDL), and autonomous proliferation by the mechanisms suggested by Benditt. The theoretical scheme presented is based largely on in vitro work, only partly substantiated by experimental and human studies, and does not explain the precise mechanisms by which all risk factors increase the susceptibility to atherosclerosis.(ABSTRACT TRUNCATED AT 400 WORDS)
本文综述了动脉粥样硬化发病机制的当前概念,重点强调了其中涉及的机制和事件与炎症机制和事件的一些相似之处。图2是这些事件的示意图总结。高脂血症或高脂血症血清的某些成分,以及其他危险因素,被认为会导致内皮损伤,从而导致血小板和/或单核细胞粘附,并释放血小板衍生生长因子(PDGF,以及其他生长因子),进而导致平滑肌迁移和增殖。显然,内皮损伤不一定是剥脱性的,实际上可能包括内皮功能改变(功能障碍);单核细胞粘附、内皮通透性增加以及生长控制紊乱可能在没有形态学上明显的内皮损伤的情况下发生。高脂血症、高血压、吸烟、免疫损伤和其他危险因素可能以不同方式,有时联合起来导致这种内皮功能障碍。平滑肌细胞产生大量的胶原蛋白、弹性蛋白和蛋白聚糖,这些构成了动脉粥样斑块的一部分。高脂血症在多个方面起作用(如前文所述),事实上,在严重高胆固醇血症患者中,如家族性高胆固醇血症患者,在没有其他危险因素的情况下,仅高脂血症就足以导致动脉粥样硬化。动脉粥样斑块中的泡沫细胞来源于巨噬细胞和平滑肌细胞;通过β-极低密度脂蛋白受体从巨噬细胞衍生而来,也可能通过乙酰低密度脂蛋白受体(如氧化低密度脂蛋白)识别的低密度脂蛋白修饰衍生而来;而来自平滑肌细胞的机制尚不确定。细胞外脂质来源于管腔渗出,特别是在高胆固醇血症存在的情况下,也来源于退化的泡沫细胞。斑块中的胆固醇积累应被视为反映了流入和流出之间的不平衡,高密度脂蛋白可能是有助于从这些积累中清除胆固醇的分子(134)。该图(右侧)还描绘了平滑肌增殖可能完全在没有内皮损伤的情况下发生的可能性。对于这种情况有几种假设机制:生长控制丧失、平滑肌直接损伤(如由低密度脂蛋白引起)以及本迪特提出的机制导致的自主增殖。所提出的理论方案主要基于体外研究,仅部分得到实验和人体研究的证实,并且没有解释所有危险因素增加动脉粥样硬化易感性的确切机制。(摘要截短于400字)